Bayer HealthCare announced that the Food and Drug Administration (FDA) has approved Finacea (azelaic acid) Foam 15% for the topical treatment of inflammatory papules and pustules of mild to moderate ...

Foamix, a specialty pharmaceutical company, and LEO Pharma have entered into a settlement and license agreement with an affiliate of Teva to resolve pending patent litigation involving Finacea Foam.

(RTTNews) - Foamix Pharmaceuticals Ltd. (FOMX) said Tuesday that, together with LEO Pharma, it has settled the Hatch-Waxman litigation with Perrigo, relating to Finacea Foam. Terms of the settlement ...

Azelaic acid 15%; foam; contains propylene glycol. Monitor patients with dark complexions for hypopigmentation. Discontinue if sensitivity or severe irritation develops. Avoid eyes, mouth, other ...

Finacea (azelaic acid) is a brand-name drug that’s prescribed for rosacea in adults. Finacea comes as a topical gel and topical foam that’s typically applied to the skin twice per day. Finacea belongs ...

The first commercial product developed for the American market by Israeli biotech start-up Foamix has received FDA approval, the company announced last week. Finacea Foam, a 15% solution of azelaic ...

BRIDGEWATER, N.J., April 02, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO) (“Menlo” or the “Company”), a biopharmaceutical company focused on developing and commercializing ...

DUBLIN, Feb. 20, 2018 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has filed a Paragraph IV Abbreviated New Drug Application with the U.S. Food and Drug ...

As with other drugs, Finacea (azelaic acid) can cause side effects, such as dryness, itching, or burning. If you are not able to tolerate side effects of Finacea, talk with your doctor or pharmacist.

REHOVOT, Israel and BRIDGEWATER, N.J., Oct. 21, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company, today announced ...